AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18308793 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 46
Study 18308793 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 46
Study 18308793 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 46
Study 17544335 — intervention group
Group type: EXPERIMENTAL
Intervention: Banded gastric bypass (n = 46)
Number of subjects: 90
Study 17544335 — intervention group
Group type: COMPARATOR
Intervention: Nonbanded gastric bypass (n = 44)
Number of subjects: 90
Study 15153211 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (2 microg.kg(‐1)) added to bupivacaine (1 mg.kg(‐1) 0.125%)
Number of subjects: 36
Study 15153211 — intervention group
Group type: COMPARATOR
Intervention: Saline added to bupivacaine (1 mg.kg(‐1) 0.125%)
Number of subjects: 36
Study 11444468 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of colloidal bismuth subcitrate and metronidazole or omeprazole, clarithromycin and amoxycillin for H. pylori eradication
Number of subjects: 8
Study 11444468 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous sulphate for anaemia treatment
Number of subjects: 8
Study 9765010 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (50 mg/day for 7 days)
Number of subjects: 60
Study 9765010 — intervention group
Group type: COMPARATOR
Intervention: Nystatin (1 mL 4 times a day for 21 days)
Number of subjects: 60
Study 7824094 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) treatment as mono-therapy (n = 36) or polytherapy (n = 16) with a mean dosage of 17 mg/kg body weight.
Number of subjects: 52
Study 7824094 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) treatment in polytherapy (n = 16).
Number of subjects: 52
Study 7824094 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) treatment as a nonretarded formulation.
Number of subjects: 52
Study 7824094 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) treatment.
Number of subjects: 52
Study 3385554 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine-fortified ORS (55 or 110 mmol/L glycine)
Number of subjects: 0
Study 3385554 — intervention group
Group type: COMPARATOR
Intervention: Standard WHO/ORS
Number of subjects: 0
Study 31343447 — intervention group
Group type: EXPERIMENTAL
Intervention: New HA fillers with decreased BDDE crosslinking
Number of subjects: 90
Study 31343447 — intervention group
Group type: COMPARATOR
Intervention: Commercially available comparator gels
Number of subjects: 90
Study 28859245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS; Tisseel)
Number of subjects: 35
Study 28859245 — intervention group
Group type: COMPARATOR
Intervention: Biodegradable synthetic polyurethane foam (Nasopore®)
Number of subjects: 35
Study 27992027 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening for 15 minutes
Number of subjects: 52
Study 27992027 — intervention group
Group type: COMPARATOR
Intervention: Conventional pediatric surgical care
Number of subjects: 52
Study 24983279 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical decompression (<24 hours)
Number of subjects: 35
Study 24983279 — intervention group
Group type: COMPARATOR
Intervention: Late surgical decompression (24‐72 hours)
Number of subjects: 35
Study 24983279 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical decompression
Number of subjects: 35
Study 24983279 — intervention group
Group type: COMPARATOR
Intervention: Late surgical decompression
Number of subjects: 35
Study 24983279 — intervention group
Group type: EXPERIMENTAL
Intervention: Both early and late surgical decompression
Number of subjects: 35
Study 23088416 — intervention group
Group type: EXPERIMENTAL
Intervention: Biceps tenotomy
Number of subjects: 128
Study 23088416 — intervention group
Group type: COMPARATOR
Intervention: Biceps tenodesis
Number of subjects: 128
Study 23088416 — intervention group
Group type: EXPERIMENTAL
Intervention: Biceps tenotomy and tenodesis
Number of subjects: 128
Study 19757207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine Needle Aspiration (FNA)
Number of subjects: 260
Study 19757207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine Needle Capillary (FNC)
Number of subjects: 260
Study 19757207 — intervention group
Group type: COMPARATOR
Intervention: Both techniques (FNA and FNC)
Number of subjects: 260
Study 17320585 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake video‐assisted thoracoscopic bullectomy with pleural abrasion under sole thoracic epidural anesthesia
Number of subjects: 43
Study 17320585 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake video‐assisted thoracoscopic bullectomy with pleural abrasion
Number of subjects: 43
Study 17320585 — intervention group
Group type: COMPARATOR
Intervention: Control group (general anesthesia with single‐lung ventilation)
Number of subjects: 43
Study 15874923 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg twice daily, supplemented by intravenous doses when necessary)
Number of subjects: 103
Study 15874923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 15874923 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 103
Study 11983815 — intervention group
Group type: EXPERIMENTAL
Intervention: palm oil
Number of subjects: 10
Study 11983815 — intervention group
Group type: EXPERIMENTAL
Intervention: transesterified palm oil
Number of subjects: 10
Study 9718869 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenic irradiation
Number of subjects: 1391
Study 9718869 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 40 years
Number of subjects: 1391
Study 9718869 — intervention group
Group type: COMPARATOR
Intervention: No splenectomy/no splenic irradiation
Number of subjects: 1391
Study 7991879 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 2463980 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate followed by irradiation
Number of subjects: 170
Study 2463980 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 170
Study 31586370 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for 12 weeks
Number of subjects: 100
Study 31586370 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 100
Study 31586370 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT)
Number of subjects: 100
Study 28468739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance (25 mg po for 21 days)
Number of subjects: 30
Study 28468739 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 30
Study 26125454 — intervention group
Group type: EXPERIMENTAL
Intervention: Local incision warming (6 post-operative treatments)
Number of subjects: 146
Study 26125454 — intervention group
Group type: COMPARATOR
Intervention: Non-warming
Number of subjects: 146
Study 24251360 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided dosing of acenocoumarol or phenprocoumon
Number of subjects: 548
Study 24251360 — intervention group
Group type: COMPARATOR
Intervention: Clinically guided dosing of acenocoumarol or phenprocoumon
Number of subjects: 548
Study 24251360 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided dosing
Number of subjects: 548
Study 24251360 — intervention group
Group type: COMPARATOR
Intervention: Clinically guided dosing
Number of subjects: 548
Study 21941167 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV/LPV
Number of subjects: 68
Study 21941167 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV
Number of subjects: 68
Study 21941167 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV
Number of subjects: 68
Study 21941167 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/EFV
Number of subjects: 68
Study 21941167 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 1 HIV-RNA change
Number of subjects: 68
Study 18385963 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric studies concerning the treatment of depressive disorders in children and adolescents; specific interventions not detailed.
Number of subjects: 0
Study 17161074 — intervention group
Group type: EXPERIMENTAL
Intervention: Special compression undergarment
Number of subjects: 481
Study 17161074 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 481
Study 14648923 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 0
Study 14648923 — intervention group
Group type: EXPERIMENTAL
Intervention: Lepirudin
Number of subjects: 0
Study 14648923 — intervention group
Group type: EXPERIMENTAL
Intervention: Danaparoid
Number of subjects: 0
Study 14648923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study 14648923 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-123
Number of subjects: 0
Study 10739784 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient perceptions of the organization and structure of the peritoneal dialysis facility
Number of subjects: 30
Study 10739784 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient perceptions of the dialysis regimen
Number of subjects: 30
Study 8922764 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 0.04 mg.mg-1 of PCA morphine
Number of subjects: 71
Study 8922764 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including droperidol 0.0 and 0.02 mg.mg-1 of PCA morphine)
Number of subjects: 71
Study 8922764 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA droperidol
Number of subjects: 71
Study 1557573 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian methods for monitoring and analysis
Number of subjects: 0
Study 3901661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine 2 g twice daily
Number of subjects: 41
Study 3901661 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide 0.10 mg/kg divided in three doses
Number of subjects: 41
Study 3901661 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2 g twice daily
Number of subjects: 41
Study 30142767 — intervention group
Group type: EXPERIMENTAL
Intervention: Socheongryong-tang (SCRT) taken twice daily for 2 weeks
Number of subjects: 30
Study 30142767 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine taken once daily for 2 weeks
Number of subjects: 30
Study 30142767 — intervention group
Group type: EXPERIMENTAL
Intervention: SCRT
Number of subjects: 30
Study 30142767 — intervention group
Group type: COMPARATOR
Intervention: SCRT and Cetirizine
Number of subjects: 30
Study 27108685 — intervention group
Group type: COMPARATOR
Intervention: Central Europe (CE)
Number of subjects: 7141
Study 27108685 — intervention group
Group type: COMPARATOR
Intervention: Western Europe (WE)
Number of subjects: 7141
Study 27108685 — intervention group
Group type: COMPARATOR
Intervention: Asia-Pacific (AP)
Number of subjects: 7141
Study 27108685 — intervention group
Group type: COMPARATOR
Intervention: Latin America (LA)
Number of subjects: 7141
Study 27108685 — intervention group
Group type: COMPARATOR
Intervention: 180-day mortality
Number of subjects: 7141
Study 25095325 — intervention group
Group type: COMPARATOR
Intervention: RHg
Number of subjects: 39
Study 25095325 — intervention group
Group type: COMPARATOR
Intervention: RHg + RME
Number of subjects: 39
Study 25095325 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 39
Study 22801290 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 23
Study 22801290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 20437771 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary groups (MultiG, n = 7)
Number of subjects: 20
Study 20437771 — intervention group
Group type: COMPARATOR
Intervention: Medical student groups (MedG, n = 10)
Number of subjects: 20
Study 18515897 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema-focused therapy (SFT)
Number of subjects: 0
Study 18515897 — intervention group
Group type: COMPARATOR
Intervention: Transference-focused psychotherapy (TFP)
Number of subjects: 0
Study 15905006 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for back strength (moment at L4/L5)
Number of subjects: 80
Study 15905006 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for back strength (force)
Number of subjects: 80
Study 15905006 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation study of prediction models
Number of subjects: 80
Study 14558052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dynamic exercise program (75 minutes, twice a week, for 2 years)
Number of subjects: 146
Study 14558052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dynamic exercise program
Number of subjects: 146
Study 10811664 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha consolidation (n = 144)
Number of subjects: 571
Study 10811664 — intervention group
Group type: COMPARATOR
Intervention: Observation alone (n = 124)
Number of subjects: 571
Study 8797643 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM; n = 24)
Number of subjects: 50
Study 8797643 — intervention group
Group type: COMPARATOR
Intervention: Anterior resection (AR; n = 26)
Number of subjects: 50
Study 1594789 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 60
Study 1594789 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study 6749152 — intervention group
Group type: EXPERIMENTAL
Intervention: vitamin K2 6 mg
Number of subjects: 148
Study 6749152 — intervention group
Group type: EXPERIMENTAL
Intervention: vitamin K2 2 mg
Number of subjects: 148
Study 6749152 — intervention group
Group type: EXPERIMENTAL
Intervention: vitamin K1 2 mg
Number of subjects: 148
Study 6749152 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 148
Study 30880626 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 31
Study 30880626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 29021322 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (target <120 mm Hg)
Number of subjects: 9361
Study 29021322 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (target <140 mm Hg)
Number of subjects: 9361
Study 29021322 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control
Number of subjects: 9361
Study 29021322 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure control
Number of subjects: 9361
Study 26752599 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1546
Study 26752599 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn-soy blended flours (CSB)
Number of subjects: 1546
Study 26752599 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CSB and LNS
Number of subjects: 1546
Study 24727030 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nebulization of 30mg ropivacaine
Number of subjects: 135
Study 24727030 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline solution instillation)
Number of subjects: 135
Study 21815168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatments with fish oil and vegetable oils
Number of subjects: 96
Study 20185009 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocycle ramp protocol
Number of subjects: 16
Study 20185009 — intervention group
Group type: COMPARATOR
Intervention: Bruce treadmill protocol
Number of subjects: 16
Study 20185009 — intervention group
Group type: COMPARATOR
Intervention: Ramp treadmill protocol
Number of subjects: 16
Study 16616883 — intervention group
Group type: EXPERIMENTAL
Intervention: Large box lifting (hand distance, 38 cm from chest)
Number of subjects: 10
Study 16616883 — intervention group
Group type: COMPARATOR
Intervention: Small box lifting (hand distance, 17 cm from chest)
Number of subjects: 10
Study 16616883 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended horizontal reach lifting (hand distance, 44.6 cm from chest)
Number of subjects: 10
Study 16616883 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency lifting (20 lifts/min)
Number of subjects: 10
Study 16281375 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 43
Study 16281375 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 43
Study 12133866 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral endopeptidase (NEP) inhibition
Number of subjects: 7
Study 12133866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 10749457 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent CRM197 pneumococcal conjugate vaccine
Number of subjects: 37868
Study 10749457 — intervention group
Group type: COMPARATOR
Intervention: Meningococcus type C CRM197 conjugate
Number of subjects: 37868
Study 8958718 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg/min of amrinone (group A)
Number of subjects: 18
Study 8958718 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg/min of amrinone (group B)
Number of subjects: 18
Study 8958718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no amrinone)
Number of subjects: 18
Study 8958718 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (both groups)
Number of subjects: 18
Study 1302788 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose midazolam
Number of subjects: 20
Study 1302788 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 20
Study 2938871 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐human atrial natriuretic peptide (alpha‐h‐ANP) at a dose of 15 pmol min‐1 kg‐1
Number of subjects: 0
Study 2938871 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐h‐ANP at a dose of 1.5 pmol min‐1 kg‐1
Number of subjects: 0
Study 2938871 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐h‐ANP
Number of subjects: 0
Study 31881927 — intervention group
Group type: EXPERIMENTAL
Intervention: PIL B (hybrid format)
Number of subjects: 1517
Study 31881927 — intervention group
Group type: COMPARATOR
Intervention: PIL A (enhanced format)
Number of subjects: 1517
Study 31881927 — intervention group
Group type: COMPARATOR
Intervention: PIL C (standard format)
Number of subjects: 1517
Study 29436052 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually guided laser balloon ablation (VGLB)
Number of subjects: 50
Study 29436052 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation
Number of subjects: 50
Study 26838569 — intervention group
Group type: EXPERIMENTAL
Intervention: Text version of assessment items
Number of subjects: 48
Study 26838569 — intervention group
Group type: COMPARATOR
Intervention: Multimedia version of assessment items
Number of subjects: 48
Study 25353194 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered wheelchair skills training (up to five 30‐min sessions based on the Wheelchair Skills Training Program 4.1)
Number of subjects: 17
Study 25353194 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 17
Study 22237302 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation
Number of subjects: 0
Study 22237302 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH challenge
Number of subjects: 0
Study 22237302 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH challenge + carotenoid supplementation
Number of subjects: 0
Study 22237302 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 20026527 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 18031444 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading (6 weeks after implant placement)
Number of subjects: 29
Study 18031444 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (6 months after implant placement)
Number of subjects: 29
Study 18031444 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 16170942 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonforced anchor group (n = 50)
Number of subjects: 75
Study 16170942 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced anchor group (n = 25)
Number of subjects: 75
Study 11859853 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 82
Study 10065670 — intervention group
Group type: COMPARATOR
Intervention: Regular nebulized salbutamol
Number of subjects: 46
Study 10065670 — intervention group
Group type: EXPERIMENTAL
Intervention: As-required (p.r.n.) nebulized salbutamol
Number of subjects: 46
Study 7733024 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg zinc supplement (ZS, n = 40)
Number of subjects: 71
Study 7733024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NZS, n = 31)
Number of subjects: 71
Study 7733024 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ZS and NZS)
Number of subjects: 71
Study 7733024 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented group (NZS)
Number of subjects: 71
Study 2144919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress by a letter informing them about their high blood pressure (Group 1)
Number of subjects: 29
Study 2144919 — intervention group
Group type: COMPARATOR
Intervention: Neutral letter (Group 2)
Number of subjects: 29
Study 30941440 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful shocks administered after presentation of some words (pain condition)
Number of subjects: 0
Study 30941440 — intervention group
Group type: COMPARATOR
Intervention: No shocks administered (pain-free condition)
Number of subjects: 0
Study 28799677 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message (TM) reminders
Number of subjects: 93
Study 26117402 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032)
Number of subjects: 128
Study 23619315 — intervention group
Group type: EXPERIMENTAL
Intervention: Dessert served after the main course
Number of subjects: 23
Study 23619315 — intervention group
Group type: EXPERIMENTAL
Intervention: Dessert served with the main course
Number of subjects: 23
Study 23619315 — intervention group
Group type: COMPARATOR
Intervention: Portion size of the main course (reference portion or 50% larger portion)
Number of subjects: 23
Study 22088414 — intervention group
Group type: COMPARATOR
Intervention: Branded etanercept (25 mg)
Number of subjects: 23